Literature DB >> 24721123

Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet.

Xiang Gao1, Xiaofang Liu1, Jie Xu1, Changhu Xue1, Yong Xue1, Yuming Wang2.   

Abstract

Trimethylamine N-oxide (TMAO) is an oxidation product of trimethylamine (TMA) and is present in many aquatic foods. Here, we investigated the effects of TMAO on glucose tolerance in high fat diet (HFD)-fed mice. Male C57BL/6 mice were randomly assigned to the control, high fat (HF), and TMAO groups. The HF group was fed a diet containing 25% fat, and the TMAO group was fed the HFD plus 0.2% TMAO for 4 weeks. After 3 weeks of feeding, oral glucose tolerance tests were performed. Dietary TMAO increased fasting insulin levels and homeostasis model assessment-estimated insulin resistance (HOMA-IR) and exacerbated the impaired glucose tolerance in HFD-fed mice. These effects were associated with the expression of genes related to the insulin signal pathway, glycogen synthesis, gluconeogenesis and glucose transport in liver. mRNA levels of the pro-inflammatory cytokine MCP-1 increased significantly and of the anti-inflammatory cytokine IL-10 greatly decreased in adipose tissue. Our results suggest that dietary TMAO exacerbates impaired glucose tolerance, obstructs the hepatic insulin signaling pathway, and causes adipose tissue inflammation in mice fed a high fat diet.
Copyright © 2014 The Society for Biotechnology, Japan. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Glucose tolerance; High fat diet; Inflammation; Insulin resistance; Trimethylamine N-oxide

Mesh:

Substances:

Year:  2014        PMID: 24721123     DOI: 10.1016/j.jbiosc.2014.03.001

Source DB:  PubMed          Journal:  J Biosci Bioeng        ISSN: 1347-4421            Impact factor:   2.894


  102 in total

Review 1.  Intestinal phospholipid and lysophospholipid metabolism in cardiometabolic disease.

Authors:  David Y Hui
Journal:  Curr Opin Lipidol       Date:  2016-10       Impact factor: 4.776

Review 2.  Targeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery.

Authors:  J Mark Brown; Stanley L Hazen
Journal:  J Biol Chem       Date:  2017-04-07       Impact factor: 5.157

3.  Structure and Function of CutC Choline Lyase from Human Microbiota Bacterium Klebsiella pneumoniae.

Authors:  Gints Kalnins; Janis Kuka; Solveiga Grinberga; Marina Makrecka-Kuka; Edgars Liepinsh; Maija Dambrova; Kaspars Tars
Journal:  J Biol Chem       Date:  2015-07-17       Impact factor: 5.157

Review 4.  The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases.

Authors:  J Mark Brown; Stanley L Hazen
Journal:  Annu Rev Med       Date:  2015       Impact factor: 13.739

5.  Trimethylamine-N-Oxide Instigates NLRP3 Inflammasome Activation and Endothelial Dysfunction.

Authors:  Krishna M Boini; Tahir Hussain; Pin-Lan Li; Sai Koka
Journal:  Cell Physiol Biochem       Date:  2017-11-06

6.  Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acids.

Authors:  Aafke W F Janssen; Tom Houben; Saeed Katiraei; Wieneke Dijk; Lily Boutens; Nieke van der Bolt; Zeneng Wang; J Mark Brown; Stanley L Hazen; Stéphane Mandard; Ronit Shiri-Sverdlov; Folkert Kuipers; Ko Willems van Dijk; Jacques Vervoort; Rinke Stienstra; Guido J E J Hooiveld; Sander Kersten
Journal:  J Lipid Res       Date:  2017-05-22       Impact factor: 5.922

Review 7.  Gut Microbial Metabolites and Blood Pressure Regulation: Focus on SCFAs and TMAO.

Authors:  Brian G Poll; Muhammad Umar Cheema; Jennifer L Pluznick
Journal:  Physiology (Bethesda)       Date:  2020-07-01

8.  Trimethylamine N-Oxide Metabolites in Early Pregnancy and Risk of Gestational Diabetes: A Nested Case-Control Study.

Authors:  Xiaoxu Huo; Jing Li; Yun-Feng Cao; Sai-Nan Li; Ping Shao; Junhong Leng; Weiqin Li; Jinnan Liu; Kai Yang; Ronald C W Ma; Gang Hu; Zhong-Ze Fang; Xilin Yang
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

Review 9.  Microbiome, trimethylamine N-oxide, and cardiometabolic disease.

Authors:  W H Wilson Tang; Stanley L Hazen
Journal:  Transl Res       Date:  2016-07-18       Impact factor: 7.012

Review 10.  Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.

Authors:  Tiantian Zhu; Mark O Goodarzi
Journal:  Curr Nutr Rep       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.